Analystreport

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating.

PROGENICS PHARMACEUTICALS  (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com